Skip to content

Princes Plans London IPO as UK Listing Market Shows Signs of Life

Princes' IPO plans signal a potential resurgence in the UK IPO market. The Chancellor's courting of potential candidates and stamp duty holiday talks further boost London's appeal, but AstraZeneca's Wall Street listing raises concerns.

In the right side there are people in the market, it's a sunny sky in the market.
In the right side there are people in the market, it's a sunny sky in the market.

Princes Plans London IPO as UK Listing Market Shows Signs of Life

Tinned tuna firm Princes has revealed plans for an Initial Public Offering (IPO) in London. This move follows recent listings of Beauty Tech Group and US data centre giant Fermi on the London Stock Exchange. Shawbrook Bank is also considering an IPO, which could boost its profile and fund growth.

Shawbrook's finance chief, Dylan Minto, has expressed confidence in London as a venue for raising capital. The bank is aiming for a valuation of up to £2 billion. Rachel Reeves, the Chancellor, has held talks with potential listing candidates, including OakNorth and Starling Bank, at a meeting hosted by Goldman Sachs. Meanwhile, digital bank Revolut is reportedly considering a dual listing in London and New York. However, AstraZeneca's decision to list its shares directly on Wall Street has raised concerns about the future of the London market. Laura Janssens, head of European investment banking at Berenberg, expects the end of 2025 to be a turning point for the UK election market.

Princes' IPO plans and Shawbrook's consideration of a listing indicate a potential resurgence in the UK stock market today. The Chancellor's talks with potential candidates and the possibility of a stamp duty holiday for newly-listed UK shares further suggest a push to make London more attractive for listings. However, the impact of AstraZeneca's Wall Street listing on the London market remains a topic of concern.

Read also:

Latest